超性心肌病中代谢过渡的机制
Conghao Tan1, Zhexuan Guo1, Junjie Zhou1
1Department of Cardiovascular Medicine, Zhenjiang First People's Hospital, Zhenjiang, Jiangsu, China.
Frontiers in physiology
|November 28, 2025
概括
超性心肌病 (HCM) 涉及心脏细胞代谢的改变. 了解这种代谢过渡是开发这种心脏病的新诊断和治疗策略的关键.
科学领域:
- 心脏病学 心脏病学
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 超性心肌病变 (HCM) 是一种常见的遗传性心脏病,具有显著的全球健康影响.
- 目前的治疗方法可以改善预后,但不能完全解决疾病负担.
- 心脏细胞中的代谢过渡越来越被认为是HCM进展的关键因素.
研究的目的:
- 阐明新陈代谢过渡在高伤性心肌病变的发病过程中的作用.
- 通过了解HCM中改变的代谢途径来确定潜在的治疗点.
主要方法:
- 审查和综合当前关于HCM代谢变化的研究.
- 分析心肌细胞中葡萄糖,脂质和氨基酸代谢的变化.
- 代谢变化的相关性与临床表现,如纤维化和扩张功能障碍.
主要成果:
- HCM心脏对糖解的依赖性增加,有氧葡萄糖氧化受损.
- 脂肪酸β-氧化中的缺陷导致脂质积累 (胺,螺旋胺).
- 改变的氨基酸代谢,包括高分支链氨基酸,与心脏重塑和胰岛素抵抗有关.
结论:
- 代谢过渡,包括葡萄糖,脂质和氨基酸路径的变化,是HCM病原体的核心.
- 了解这些代谢变化对于开发HCM新型诊断和治疗策略至关重要.
- 准代谢途径可能会改善患有高伤心肌病的患者的治疗结果和生活质量.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
374
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374
Heart Failure II: Pathophysiology
685
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
685
Cardiomyopathy V: Interprofessional Care
314
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
314
Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
Cardiomyopathy I: Introduction and Classification
479
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
479
Cardiomyopathy II: Dilated Cardiomyopathy
447
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
447


